Semaglutide’s Impact on Hypertension in American Males: A Multi-Center Trial Analysis
Reading Time: 3 minutes Introduction Hypertension, a prevalent cardiovascular risk factor, affects a significant portion of the American male population. The management of this condition is crucial for preventing severe cardiovascular events. Recent research has explored the potential of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, traditionally used for type 2 diabetes management, in the treatment of hypertension. This article discusses the findings from a multi-center clinical trial that investigated the role of semaglutide in managing hypertension among American males. Background on Semaglutide Semaglutide, known commercially as Ozempic and Wegovy, has been recognized for its efficacy in managing blood glucose levels and promoting weight...


